Occlusion of Venous Femoropopliteal Bypass by a Starclose Device After Endovascular Cardiac Catheterization

Excerpt

More than 1 million patients undergo percutaneous cardiac catheterization worldwide every year. Overall vascular complications occur in 0.5% to 1.7% of patients undergoing diagnostic catheterization and in ≤5% of patients undergoing percutaneous interventions [1]. Major vascular complications seem to have diminished over time and have reached 2% in some studies [2]. They are, however, followed by surgery in a high percentage of patients (≤40%) [3]. Vascular closure devices (VCDs) have been on the market for nearly 15 years. They permit early patient ambulation and discharge. Up until now, however, they failed to prove cost-effectiveness and a lower rate of vascular complications. The Starclose device was approved by the United States Food and Drug Administration in 2005. At least one randomized trial [4] has proven the safety and adequacy of this device. This is a case report of a major vascular complication of the puncture site after closure using the Starclose device. …